[1]
LAXMI, B.V. et al. 2025. MAXIMIZING THE POTENTIAL OF IBRUTINIB: MULTI-FACTOR OPTIMIZATION AND INTERACTION ANALYSIS FOR IMPROVED NANOBUBBLE FORMULATION AND BIOAVAILABILITY PERFORMANCE. International Journal of Applied Pharmaceutics. 17, 5 (Sep. 2025), 214–226. DOI:https://doi.org/10.22159/ijap.2025v17i5.54081.